Behavioral Activation and Risk Reduction for Stimulant Use Among Sexually Active Adolescents and Young Adults
ConditionHIV
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age16-24
SponsorWestat
About this trial
The use of behavioral intervention to reduce stimulant use and concurrent HIV sexual transmission risk.
Eligibility criteria
Qualifiers
Age 16-24 years, inclusive, at enrollment
Male or female
Self-reports condomless anal or vaginal sex while using stimulants (5 hour prior to, or during sex) within the last 4 months; stimulants is defined as crystal methamphetamine, cocaine, and MDMA (e.g., ecstasy, molly)
Willing and able to provide written informed consent for study participation
Disqualifiers
Unable to provide informed consent due to severe mental or physical illness
Concurrent enrollment in another HIV prevention or treatment study (enrollment in a substance treatment program is acceptable)
Randomized to IMPACT arm prior to March 2025 study stop
Non-English-speaking
Trial design
Treatments tested in this trial
- IMPACT
- eSOC
Treatment groups
360 Participants
are divided into 2 treatment groupsSponsors and collaborators
Westat
Lead sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator
National Institute on Drug Abuse (NIDA)
Collaborator
National Institute of Mental Health (NIMH)
Collaborator
Source ClinicalTrials.gov